Literature DB >> 18619694

Bluetongue in Europe and the Mediterranean Basin: history of occurrence prior to 2006.

Philip S Mellor1, Simon Carpenter, Lara Harrup, Matthew Baylis, Peter P C Mertens.   

Abstract

Bluetongue virus (BTV) exists around the world in a broad band covering much of the Americas, Africa, southern Asia and northern Australia. Historically, it also occasionally occurred in the southern fringes of Europe. It is considered to be one of the most important diseases of domestic livestock. Recently BTV has extended its range northwards into areas of Europe never before affected and has persisted in many of these locations causing the greatest epizootic of bluetongue (BT), the disease caused by BTV, on record. Indeed, the most recent outbreaks of BT in Europe are further north than this virus has ever previously occurred anywhere in the world. The reasons for this dramatic change in BT epidemiology are complex but are linked to recent extensions in the distribution of its major vector, Culicoides imicola, to the involvement of novel Culicoides vector(s) and to on-going climate-change. This paper investigates these recent outbreaks in the European theatre, up to the beginning of 2006, highlights prospects for the future and sets the scene for the following papers in this special issue.

Entities:  

Mesh:

Year:  2008        PMID: 18619694     DOI: 10.1016/j.prevetmed.2008.06.002

Source DB:  PubMed          Journal:  Prev Vet Med        ISSN: 0167-5877            Impact factor:   2.670


  47 in total

Review 1.  The arrival, establishment and spread of exotic diseases: patterns and predictions.

Authors:  Sarah E Randolph; David J Rogers
Journal:  Nat Rev Microbiol       Date:  2010-04-07       Impact factor: 60.633

Review 2.  Prospects for improved bluetongue vaccines.

Authors:  Polly Roy; Mark Boyce; Robert Noad
Journal:  Nat Rev Microbiol       Date:  2009-02       Impact factor: 60.633

Review 3.  From the bluetongue vaccination campaigns in sheep to overimmunization and ovine ASIA syndrome.

Authors:  J Asín; M Pérez; P Pinczowski; M Gimeno; L Luján
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

4.  The evolutionary dynamics of bluetongue virus.

Authors:  Giovanna Carpi; Edward C Holmes; Andrew Kitchen
Journal:  J Mol Evol       Date:  2010-06-05       Impact factor: 2.395

5.  Genome sequence of a reassortant strain of bluetongue virus serotype 23 from western India.

Authors:  Sushila Maan; Narender S Maan; Marc Guimera; Kyriaki Nomikou; Karam Pal Singh; Gillian Pullinger; Manjunatha N Belaganahalli; Peter P C Mertens
Journal:  J Virol       Date:  2012-06       Impact factor: 5.103

6.  Real-time quantitative reverse transcription-PCR assays specifically detecting bluetongue virus serotypes 1, 6, and 8.

Authors:  Bernd Hoffmann; Michael Eschbaumer; Martin Beer
Journal:  J Clin Microbiol       Date:  2009-07-15       Impact factor: 5.948

7.  Full genome characterisation of bluetongue virus serotype 6 from the Netherlands 2008 and comparison to other field and vaccine strains.

Authors:  Sushila Maan; Narender S Maan; Piet A van Rijn; René G P van Gennip; Anna Sanders; Isabel M Wright; Carrie Batten; Bernd Hoffmann; Michael Eschbaumer; Chris A L Oura; Abraham C Potgieter; Kyriaki Nomikou; Peter P C Mertens
Journal:  PLoS One       Date:  2010-04-23       Impact factor: 3.240

8.  The spread of bluetongue virus serotype 8 in Great Britain and its control by vaccination.

Authors:  Camille Szmaragd; Anthony J Wilson; Simon Carpenter; James L N Wood; Philip S Mellor; Simon Gubbins
Journal:  PLoS One       Date:  2010-02-22       Impact factor: 3.240

9.  A modeling framework to describe the transmission of bluetongue virus within and between farms in Great Britain.

Authors:  Camille Szmaragd; Anthony J Wilson; Simon Carpenter; James L N Wood; Philip S Mellor; Simon Gubbins
Journal:  PLoS One       Date:  2009-11-05       Impact factor: 3.240

10.  Assay development and high-throughput antiviral drug screening against Bluetongue virus.

Authors:  Qianjun Li; Clinton Maddox; Lynn Rasmussen; Judith V Hobrath; Lucile E White
Journal:  Antiviral Res       Date:  2009-06-24       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.